[Kr 339 in the treatment of parkinsonian tremor].
D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D014202:Tremor / Q000188:drug therapy
D000978:Antiparkinson Agents; D001952:Bridged-Ring Compounds; D010276:Parasympatholytics; D010919:Placebos; D004295:Dihydroxyphenylalanine; C006088:bornaprine; D000547:Amantadine
Kr 339 parkinsonismivapinan hoidossa